Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-13 Sale |
2025-03-17 5:14 pm |
Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO |
4,501 | $16.94 | $76,247 | 72,343 (Direct) |
View |
| 2024-11-26 Purchase |
2024-11-27 4:39 pm |
Neurogene Inc. | NGNE | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner |
48,770 | $25.83 | $1,259,623 | 1,717,127 (Indirect) |
View |
| 2024-11-22 Purchase |
2024-11-25 9:29 pm |
Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO |
24,000 | $20.48 | $491,400 | 76,844 (Direct) |
View |
| 2024-11-22 Purchase |
2024-11-25 9:29 pm |
Neurogene Inc. | NGNE | McMinn Rachel Chief Executive Officer |
47,500 | $20.4 | $969,000 | 1,297,859 (Direct) |
View |
| 2023-08-15 Purchase |
2023-08-17 5:08 pm |
Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner |
2,285,342 | $0.64038 | $1,463,487 | 5,617,469 (Indirect Direct) |
View |
| 2023-08-11 Sale |
2023-08-14 4:06 pm |
Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Interim CFO, Prin Acct Off |
1,323 | $0.6184 | $818 | 21,637 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-26 Option Award |
2025-03-28 9:30 pm |
N/A 2035-03-26 |
Neurogene Inc. | NGNE | Cobb Stuart Chief Scientific Officer |
50,100 | $0 | 70,491 (Direct) |
View |
| 2025-03-26 Option Award |
2025-03-28 9:29 pm |
N/A 2035-03-26 |
Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO |
142,300 | $0 | 214,643 (Direct) |
View |
| 2025-03-26 Option Award |
2025-03-28 9:28 pm |
N/A 2035-03-26 |
Neurogene Inc. | NGNE | Jordan Julie Chief Medical Officer |
58,700 | $0 | 58,700 (Direct) |
View |
| 2025-03-26 Option Award |
2025-03-28 9:27 pm |
2025-03-26 N/A |
Neurogene Inc. | NGNE | McMinn Rachel Chief Executive Officer |
167,400 | $0 | 1,417,759 (Direct) |
View |
Ownership |
2024-11-27 4:36 pm |
N/A N/A |
Neurogene Inc. | NGNE | Samsara BioCapital GP LLC Samsara BioCapital L.P. AKKARAJU SRINIVAS 10% Owner |
0 | $0 | 1,755,427 (Indirect) |
View |
| 2024-06-14 Option Award |
2024-06-17 2:37 pm |
N/A 2034-06-14 |
Neurogene Inc. | NGNE | Woods Robert Keith Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-17 2:37 pm |
N/A 2034-06-14 |
Neurogene Inc. | NGNE | PALEKAR ROHAN Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-17 2:36 pm |
N/A 2034-06-14 |
Neurogene Inc. | NGNE | BAFFI ROBERT Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-17 2:36 pm |
N/A 2034-06-14 |
Neurogene Inc. | NGNE | Noonberg Sarah B. Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-17 2:35 pm |
N/A 2034-06-14 |
Neurogene Inc. | NGNE | Freedland Cory S. Director |
7,700 | $0 | 7,700 (Direct) |
View |
| 2024-03-13 Option Award |
2024-03-14 8:54 pm |
N/A 2034-03-13 |
Neurogene Inc. | NGNE | McMinn Rachel Chief Executive Officer |
93,282 | $0 | 93,282 (Direct) |
View |
| 2024-03-13 Option Award |
2024-03-14 8:53 pm |
N/A 2034-03-13 |
Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO |
85,803 | $0 | 106,744 (Direct) |
View |
| 2024-03-13 Option Award |
2024-03-14 8:51 pm |
N/A 2034-03-13 |
Neurogene Inc. | NGNE | Cobb Stuart Chief Scientific Officer |
54,841 | $0 | 54,841 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 7:01 pm |
N/A 2034-01-16 |
Neurogene Inc. | NGNE | Woods Robert Keith Director |
15,400 | $0 | 15,400 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 6:58 pm |
N/A 2034-01-16 |
Neurogene Inc. | NGNE | PALEKAR ROHAN Director |
15,400 | $0 | 15,400 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 6:56 pm |
N/A 2034-01-16 |
Neurogene Inc. | NGNE | Noonberg Sarah B. Director |
15,400 | $0 | 15,400 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 6:53 pm |
N/A 2034-01-16 |
Neurogene Inc. | NGNE | Freedland Cory S. Director |
15,400 | $0 | 15,400 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 6:51 pm |
N/A 2034-01-16 |
Neurogene Inc. | NGNE | BAFFI ROBERT Director |
15,400 | $0 | 15,400 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-18 6:48 pm |
N/A 2034-01-16 |
Neurogene Inc. | NGNE | Jordan Julie Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
Ownership |
2023-12-26 6:16 pm |
N/A N/A |
Neurogene Inc. | NGNE | Cvijic Christine Mikail President and CFO |
0 | $0 | 126,750 (Direct) |
View |
Ownership |
2023-12-26 6:12 pm |
N/A N/A |
Neurogene Inc. | NGNE | McMinn Rachel Chief Executive Officer |
0 | $0 | 1,314,558 (Direct) |
View |
Ownership |
2023-12-26 6:10 pm |
N/A 2030-10-15 |
Neurogene Inc. | NGNE | BAFFI ROBERT Director |
0 | $0 | 11,642 (Direct) |
View |
Ownership |
2023-12-26 6:05 pm |
N/A 2030-10-15 |
Neurogene Inc. | NGNE | Cobb Stuart Chief Scientific Officer |
0 | $0 | 74,226 (Direct) |
View |
| 2023-12-18 Option Award |
2023-12-20 6:43 pm |
N/A N/A |
Neurogene Inc. | NGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Former 10% Owner Director |
2,877,250 | $0 | 7,831,766 (Indirect) |
View |
| 2023-10-05 Exercise |
2023-10-10 4:22 pm |
N/A N/A |
Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner |
592,650 | $0 | 3,363,045 (Indirect) |
View |
| 2023-08-10 Exercise |
2023-08-14 4:06 pm |
N/A N/A |
Neoleukin Therapeutics Inc. | NLTX | Smith Sean Michael Interim CFO, Prin Acct Off |
5,000 | $0 | 21,637 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:03 pm |
N/A 2033-06-07 |
Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director |
50,000 | $0 | 50,000 (Indirect) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:28 pm |
N/A 2033-06-07 |
Neoleukin Therapeutics Inc. | NLTX | SIMPSON TODD E Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:27 pm |
N/A 2033-06-07 |
Neoleukin Therapeutics Inc. | NLTX | PALEKAR ROHAN Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:26 pm |
N/A 2033-06-07 |
Neoleukin Therapeutics Inc. | NLTX | Noonberg Sarah B. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:25 pm |
N/A 2033-06-07 |
Neoleukin Therapeutics Inc. | NLTX | Lavelle Erin Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:24 pm |
N/A 2033-06-07 |
Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director |
25,000 | $0 | 25,000 (Direct) |
View |